2019 Research Articles
Overview
Pathophysiology
Causes/ Risk Factors
Appendicitis NEW
Associated Conditions
Anorexia Nervosa NEW
Testing
Methane
Hydrogen Sulfide
Treatment
Antibiotics
Bacteriophage NEW
Probiotics
Acupuncture
Fecal Microbiota Transplantation (FMT)
Diet
FODMAP Diet
- The Spectrum of Small Intestinal Bacterial Overgrowth (SIBO). PMID: 30645678
- Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management. PMID: 31584459
- Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review. PMID: 31552207
- Small Intestinal Bacterial Overgrowth. PMID: 31536241
- Is A Real Condition? PMID: 31550680
Pathophysiology
- Infection-Induced Intestinal Dysbiosis Is Mediated by Macrophage Activation and Nitrate Production. PMID: 31138751
- Mo1615 – Fat-Soluble Vitamins, B12, and Iron Deficiency in Patients with Coliform Small Intestinal Bacterial Overgrowth. DOI: 10.1016/S0016-5085(19)38959-0
- 4 – First Large Scale Study Defining the Characteristic Microbiome Signatures of Small Intestinal Bacterial Overgrowth (SIBO): Detailed Analysis from the Reimagine Study. DOI: 10.1016/S0016-5085(19)36776-9
- Sa1755 – Presenting Symptom Severity and Health-Related Quality of Life Do Not Predict Lactulose Breath Test Outcomes in Patients with Suspected Small Intestinal Bacterial Overgrowth. DOI: 10.1016/S0016-5085(19)37822-9
- Sa1911 – Analysis of the Small Intestinal Microbiome Reveals Marked Differences from Stool Microbiome in a Large Scale Human Cohort: Redefining the “Gut Microbiome”. DOI: 10.1016/S0016-5085(19)37977-6
- Carbohydrate Intolerance and Disaccharidase Measurement - a Mini-Review. PMID: 31857738
Causes/ Risk Factors
Appendicitis NEW
- 1149 – Microbial Sequencing of the Appendiceal Microbiome Reveals Elevated Levels of C. Jejuni in Acute Appendicitis doi: 10.1016/S0016-5085(19)37416-5
- 443 – Intestinal Biofilms are an Endoscopic Feature of Irritable Bowel Syndrome. DOI: 10.1016/S0016-5085(19)37016-7
- Increased fasting small-bowel water content in untreated coeliac disease and scleroderma as assessed by magnetic resonance imaging. PMID: 31839961
- Sa1954 – Post Infection IBS (PI-IBS) is Very Infrequent in Mexico and Patients Have Similar Characteristics Than Those with Non Pi-Ibs Ones. DOI: 10.1016/S0016-5085(19)38020
- Bowel symptoms in patients that receive proton pump inhibitors. Results of a multicenter survey in Mexico. PMID: 29678362
- 979 – A Large Scale Evaluation of the Small Intestinal Microbiome in Subjects on Proton Pump Inhibitors. DOI: 10.1016/S0016-5085(19)37311-1
- Lactulose Breath Testing Can Be a Positive Predictor Before Weight Gain in Participants with Obesity Submitted to Roux-en-Y Gastric Bypass. PMID: 31187458
- Small intestinal bacterial overgrowth is common after gastrectomy but with little impact on nutritional status. DOI: 10.1016/j.gastre.2019.01.007
- Bariatric Surgery and Its Complications in Inflammatory Bowel Disease Patients. PMID: 31626698
- Partially hydrolyzed guar gum alleviates small intestinal mucosal damage after massive small bowel resection along with changes in the intestinal microbiota. PMID: 31515113
- Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Meta-Analysis. PMID: 31605277
- Effect of eradicating hydrogen-forming small intestinal bacterial overgrowth with rifaximin on body weight change. PMID: 31861004
Associated Conditions
Anorexia Nervosa NEW
- Microbiota, Microbial Metabolites, and Barrier Function in A Patient with Anorexia Nervosa after Fecal Microbiota Transplantation. PMID: 31510101
- 858 – Therapeutic Response to Small Intestinal Bacterial Overgrowth (SIBO) in Irritable Bowel Syndrome (IBS). is It Useful to Test For?. DOI: 10.1016/S0016-5085(19)37267-1
- Mo1610 – Characterizing Symptoms of Brain Fogginess and Its Association with D-Lactic Acidosis and Sibo. DOI: 10.1016/S0016-5085(19)38954-1
- Clinical evaluation and treatment of chronic bowel symptoms following cancer in the colon and pelvic organs. PMID: 30698052
- Association between small intestinal bacterial overgrowth and toll-like receptor 4 in patients with pancreatic carcinoma and cholangiocarcinoma. PMID: 30457560
- Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis. DOI:10.1016/j.hbpd.2018.11.002
- Relationship of TLR2 and TLR4 expressions on the surface of peripheral blood mononuclear cells to small intestinal bacteria overgrowth in patients with hepatocellular carcinoma. PMID: 31082340
- METABOLIC ALTERATIONS IN CELIAC DISEASE OCCURRING AFTER FOLLOWING A GLUTEN-FREE DIET. DOI: 10.1159/000495749
- Impact of Small Intestine Bacterial Overgrowth on Response to a Nutritional Intervention in Bangladeshi Children from an Urban Community. PMID: 30479249
- Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review. PMID: 31552207
- Increased Fecal Lactobacillus Is Associated With a Positive Glucose Hydrogen Breath Test in Bangladeshi Children. PMID: 31281862
- Monitoring of long-term parenteral nutrition in children with intestinal failure. PMID: 31061893
- Gastrointestinal Conditions in Children With Severe Feeding Difficulties. PMID: 31020010
- Long-term outcomes of ultrashort bowel syndrome due to malrotation with midgut volvulus managed at an interdisciplinary pediatric intestinal rehabilitation center. PMID: 30826119
- Risk Factors of Ambulatory Central Line-Associated Bloodstream Infection in Pediatric Short Bowel Syndrome. PMID: 31179578
- Small intestinal bacterial overgrowth: could it be associated with chronic abdominal pain in children with allergic diseases? PMID: 31617366
- Small intestinal bacterial overgrowth in children with intestinal failure on home parenteral nutrition. PMID: 31633044
- A Mechanistic Insight Into the Role of Gut Microbiota in the Pathogenesis of Primary Sclerosing Cholangitis. DOI:10.1053/j.gastro.2019.10.012
- Gut reaction: impact of systemic diseases on gastrointestinal physiology and drug absorption. DOI: 10.1016/j.drudis.2018.11.009
- Diabetes and the gastrointestinal tract. DOI: 10.1016/j.mpmed.2019.04.011
- Overview on the management of diverticular disease by Italian General Practitioners. DOI: 10.1016/j.dld.2018.07.015
- A Set Up for SIBO. PMID: 30639676
- Environmental enteric dysfunction and growth. PMID: 30629923
- High occurrence of small intestinal bacterial overgrowth in primary biliary cholangitis. PMID: 31373141
- Hydrogen- and Methane-Based Breath Testing and Outcomes in Patients With Heart Failure. DOI: 10.1016/j.cardfail.2018.10.004
- Impact of intestinal microbiota in patients with heart failure: A systematic review. DOI: 10.1016/j.medcle.2019.06.017
- Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment. PMID: 31496621
- Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. PMID: 30735254
- Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis. PMID: 31754993
- Bariatric Surgery and Its Complications in Inflammatory Bowel Disease Patients. PMID: 31626698
- Serum Unconjugated Bile Acids and Small Bowel Bacterial Overgrowth in Pediatric Intestinal Failure: A Pilot Study. PMID: 30035316
- Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea. PMID: 31688023
- Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance. PMID: 31765575
- Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis. PMID: 31754993
- A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome. PMID: 31750966
- Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome. PMID: 31674052
- Irritable bowel syndrome and gut microbiota. PMID: 31789724
- Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease. PMID:30915401
- An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity. PMID: 30896956
- The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience. PMID: 30894137
- Alcoholic liver disease and mast cells: What's your gut got to do with it? https://doi.org/10.1016/j.livres.2019.02.002
- Role of the intestinal microbiome in liver fibrosis development and new treatment strategies. DOI: 10.1016/j.trsl.2019.02.005
- Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis. DOI:10.1016/j.hbpd.2018.11.002
- An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity. PMID: 30896956
- Su1083 – Small Intestinal Bacterial Overgrowth and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. DOI: 10.1016/S0016-5085(19)40180-7
- Mo2015 – The Role of Small Intestinal Bacteria Overgrowth in Nonalcoholic Fatty Liver Disease. DOI: 10.1016/S0016-5085(19)39278-9
- Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis? PMID: 31767551
- The relationship between vitamin C status, the gut-liver axis, and metabolic syndrome. DOI: 10.1016/j.redox.2018.101091
- An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity. PMID: 30896956
- Mo2023 – Association Between Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Metaanalysis. DOI: 10.1016/S0016-5085(19)39287-X
- Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Meta-Analysis. PMID: 31605277
- Effect of eradicating hydrogen-forming small intestinal bacterial overgrowth with rifaximin on body weight change. PMID: 31861004
- Factors That Affect Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Pancreatitis: A Systematic Review, Meta-Analysis, and Meta-Regression. PMID: 31517648
- Small Intestinal Bacterial Overgrowth Is Common in Chronic Pancreatitis and Associates With Diabetes, Chronic Pancreatitis Severity, Low Zinc Levels, and Opiate Use. PMID: 31008737
- Association between increased breath hydrogen methane concentration and prevalence of glucose intolerance in acute pancreatitis. PMID: 31689699
- Altered diversity and composition of gut microbiota in Chinese patients with chronic pancreatitis. DOI: 10.1016/j.pan.2019.11.013
- Gut reaction: impact of systemic diseases on gastrointestinal physiology and drug absorption. DOI: 10.1016/j.drudis.2018.11.009
- Triggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis. DOI:10.1016/j.tins.2018.09.007
- Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease. PMID: 31681153
- Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson's disease. PMID: 31678900
- Restless Leg Syndrome: Does It Start With A Gut Feeling? https://doi.org/10.1093/sleep/zsz067.008
- Could problems in the bedroom come from our intestines? A preliminary study of IBS and its impact on female sexuality. PMID: 31488791
- Long-term outcomes of ultrashort bowel syndrome due to malrotation with midgut volvulus managed at an interdisciplinary pediatric intestinal rehabilitation center. PMID: 30826119
- DPP4 inhibitor reinforces cell junction proteins in mouse model of short syndrome. PMID: 31576468
- Risk Factors of Ambulatory Central Line-Associated Bloodstream Infection in Pediatric Short Bowel Syndrome. PMID: 31179578
- Impact of Oral-Cecal Transit Time on the Interpretation of Lactulose Breath Tests After RYGB: a Personalized Approach to the Diagnosis of SIBO. PMID: 30627990
- Gut Microbiota Imbalance Can Be Associated with Non-malabsorptive Small Bowel Shortening Regardless of Blind Loop. PMID: 30293133
- Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients. PMID: 30729669
- Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis. PMID: 31549334
Testing
- Impact of Oral-Cecal Transit Time on the Interpretation of Lactulose Breath Tests After RYGB: a Personalized Approach to the Diagnosis of SIBO. PMID: 30627990
- Serum Unconjugated Bile Acids and Small Bowel Bacterial Overgrowth in Pediatric Intestinal Failure: A Pilot Study. PMID: 30035316
- Noninvasive Magnetogastrography Detects Erythromycin-Induced Effects on the Gastric Slow Wave. PMID: 29993499 (MMC testing)
- BREATH TESTS FOR SMALL INTESTINAL BACTERIAL OVERGROWTH DIAGNOSIS: A SYSTEMATIC REVIEW WITH META-ANALYSIS. https://doi.org/10.1016/S1590-8658(19)30442-6
- Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels. PMID: 31152332
- Gastric, small bowel and colonic motility and breath-testing. DOI: 10.1016/j.mpmed.2019.03.006
- First Large Scale Study Defining the Characteristic Microbiome Signatures of Small Intestinal Bacterial Overgrowth (SIBO): Detailed Analysis from the Reimagine Study. DOI: 10.1016/S0016-5085(19)36776
- Su1949 – Small Intestinal Aspirates Require Specific Treatment to Optimize Microbial Analysis: Validation of a Novel Technique from the Reimagine Study DOI: https://doi.org/10.1016/S0016-5085(19)38583-X
- Sa1912 – Revealing the Entire Intestinal Microbiota and Its Associations to the Genetic, Immunologic, and Neuroendocrine Ecosystems: Methodology for the Reimagine Study. DOI: https://doi.org/10.1016/S0016-5085(19)37978-8
- P.06.12 BREATH TESTS FOR SMALL INTESTINAL BACTERIAL OVERGROWTH DIAGNOSIS: A SYSTEMATIC REVIEW WITH META-ANALYSIS. DOI: 10.1016/S1590-8658(19)30442-6
- Tu1873 – Bowel Cleansing May Affect Diagnostic Yield of Small Bowel Aspirates for Diagnosis of Sibo in Patients with Diarrhea. DOI: 10.1016/S0016-5085(19)39856-7
- Tu1600 – Air Or Carbon Dioxide Insufflation in Upper Endoscopies and the Yield of Quantitative Small Bowel Aspirate Cultures. DOI: 10.1016/S0016-5085(19)39605-2
- Sa1953 – Pictograms are Highly Effective for Diagnosing Abdominal Bloating and Distension in Patients with Irritable Bowel Syndrome (IBS). DOI: 10.1016/S0016-5085(19)38019-9
- Su1949 – Small Intestinal Aspirates Require Specific Treatment to Optimize Microbial Analysis: Validation of a Novel Technique from the Reimagine Study. DOI: 10.1016/S0016-5085(19)38583-X
- Changes in Fecal Calprotectin After Rifaximin Treatment in Patients With Nonconstipated Irritable Bowel Syndrome. DOI: 10.1016/j.amjms.2018.11.004.
- Reaction of antibodies to Campylobacter jejuni and cytolethal distending toxin B with tissues and food antigens. PMID: 30862994
- Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity. PMID: 31563879
- Characterization of Proximal Small Intestinal Microbiota in Patients With Suspected Small Intestinal Bacterial Overgrowth: A Cross-Sectional Study. PMID: 3146469
- Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders. PMID: 31043597
- Optimizing microbiome sequencing for small intestinal aspirates: validation of novel techniques through the REIMAGINE study. PMID: 31675917
- Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea. PMID: 31688023
- Carbohydrate Intolerance and Disaccharidase Measurement - a Mini-Review. PMID: 31857738
- Diagnostic Utility of Carbohydrate Breath Tests for SIBO, Fructose, and Lactose Intolerance. PMID: 31617133
- Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis. PMID: 31754993
- Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome. PMID: 31674052
- Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis. PMID: 31743632
Methane
- Tu1887 – Patients with Appendectomy Have Significantly Less Methane in Their Exhaled Breath: is the Appendix a Vestigial Organ Or an Important Reservoir for Methanogens? doi: 10.1016/S0016-5085(19)39870-1
- Tu1897 – Enteric Methane Or Hydrogen Production in Patients with Unexplained Gastrointestinal Symptoms: Associations with Age, Symptoms and Proton Pump Inhibitors doi: 10.1016/S0016-5085(19)39880-4
- Su1635 – Oral Iron Supplementation, Microbiome Related Methanogenesis and Constipation - a Novel Model to Explain and Age Old Problem doi: 10.1016/S0016-5085(19)38374-X
Hydrogen Sulfide
- SIBO AS AN ADAPTATION: A PROPOSED ROLE FOR HYDROGEN SULFIDE NDNR
- Sa1918 – Jejunal But Not Colonic Hydrogen Sulfide Increased Portal Blood Flow But Not Portal Pressure. DOI: 10.1016/S0016-5085(19)37984-3
- Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis. PMID: 31754993
Treatment
Antibiotics
- Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis. PMID: 31549334
- Effect of Rifaximin Treatment on Endotoxemia and Insulin Sensitivity in Humans. PMID: 31428718
- Changes in Fecal Calprotectin After Rifaximin Treatment in Patients With Nonconstipated Irritable Bowel Syndrome. DOI: 10.1016/j.amjms.2018.11.004.
- Su1589 – Predictive Factors of Response to Rifaximin in Irritable Bowel Syndrome and Bacterial Overgrowth. DOI: 10.1016/S0016-5085(19)38328-3
- 444 – Rifaximin for Improving Abdominal Pain and Bloating Symptoms in Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D) Using Modified Definitions of Pain Response. DOI: 10.1016/S0016-5085(19)37017-9
- Mo1545 – Characterization of Abdominal Pain Response to Rifaximin in Patients with Irritable Bowel Syndrome with Diarrhea (IBSD), by Baseline Pain Severity
- Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea. PMID: 31688023
Bacteriophage NEW
- Transplanting Fecal Virus-Like Particles Reduces High-Fat Diet-Induced Small Intestinal Bacterial Overgrowth in Mice. PMID: 31750259
- Rikkunshito Depolarizes Pacemaker Potentials of Cultured Interstitial Cells of Cajal through Ghrelin Receptors in Murine Small Intestine. PMID: 30889598
- Prucalopride for the treatment of constipation: a view from 2015 and beyond. PMID:30791758
- Prucalopride, A Recently Approved Drug by the Food and Drug Administration for Chronic Idiopathic Constipation. PMID: 30820411
- The effect of pyridostigmine on small intestinal bacterial overgrowth(SIBO) and plasma inflammatory biomarkers in HIV-associated autonomic neuropathies. PMID: 31098925
- Mo1584 – Effectiveness of Lanreotide in the Treatment of Patients with Small Bowel Motility Disorder (SBMD). DOI: 10.1016/S0016-5085(19)38928-0
- In brief: Tegaserod (Zelnorm) returns. PMID: 31169806
- Prucalopride (Motegrity) for chronic idiopathic constipation. PMID: 31170120
- Clinical Efficacy and Safety Profile of Prucalopride in Chronic Idiopathic Constipation. PMID: 31218146
- Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350. PMID: 31134513
- Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study. PMID: 31134512
- Use of prucalopride in adults with chronic idiopathic constipation. PMID: 31096799
Probiotics
- Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis. PMID: 31549334
- Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth. PMID: 29508268
- Sa1936 – Efficacy and Safety of Saccharomyces Boulardii Cncm I -745 in the Treatment of Small Intestinal Bacterial Overgrowth in Patients Suffering Irritable Bowel Syndrome with Diarrhea. DOI: 10.1016/S0016-5085(19)38002-3
- Mo1543 – The Effect of Low Fodmap Diet Management in Combination with Bifidobacteria on IBS Patients in Western China:A Prospective Randomized Trail. DOI: 10.1016/S0016-5085(19)38887-0
- Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial. PMID31114137
Acupuncture
- Acupuncture protects the interstitial cells of Cajal by regulating miR-222 in a rat model of post-operative ileus. PMID: 30852906
Fecal Microbiota Transplantation (FMT)
- Microbiota, Microbial Metabolites, and Barrier Function in A Patient with Anorexia Nervosa after Fecal Microbiota Transplantation. PMID: 31510101
- Tu1878 – Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS): A Systematic Review and Meta-Analysis. DOI: 10.1016/S0016-5085(19)39861-
Diet
- Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota. PMID: 30626117
- The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence. PMID: 31505870
- The role of diet in irritable bowel syndrome: implications for dietary advice. PMID: 31468640
- Reaction of antibodies to Campylobacter jejuni and cytolethal distending toxin B with tissues and food antigens. PMID: 30862994
- Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders. PMID: 31043597
- The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence. PMID: 31505870
- The role of diet in irritable bowel syndrome: implications for dietary advice. PMID: 31468640
- Reaction of antibodies to Campylobacter jejuni and cytolethal distending toxin B with tissues and food antigens. PMID: 30862994
FODMAP Diet
- Tolerability of FODMAP - reduced diet in irritable bowel syndrome - efficacy, adherence, and body weight course. PMID: 30873577
- Joint Hypermobility Syndrome Affects Response to a Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide and Polyol Diet in Irritable Bowel Syndrome Patients: A Retrospective Study. PMID: 30834032
- Self-reported Food Intolerance in Korean Patients With Irritable Bowel Syndrome. PMID: 30827068
- REPLY TO THE LETTER: Prebiotics Versus Low Fodmap Diet: An Interpretative Nightmare. PMID: 30794765
- Exit Gluten-Free and Enter Low FODMAPs: A Novel Dietary Strategy to Reduce Gastrointestinal Symptoms in Athletes. PMID: 30671907
- Effect of a short-term low fermentable oligiosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diet on exercise-related gastrointestinal symptoms. PMID: 30646926
- Low-FODMAP Diet Is Associated With Improved Quality of Life in IBS Patients-A Prospective Observational Study. PMID: 30644587
- Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research. PMID: 30589971
- Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link? PMID: 30543574
- The Effect of Diet on Irritable Bowel Syndrome Symptoms and Its Role in the Treatment Plan (P12-001-19). PMID: 31224179
- How Patients with IBS Use Low FODMAP Dietary Information Provided by General Practitioners and Gastroenterologists: A Qualitative Study. PMID: 31205130
- Influence of Dietary Fiber in Low FODMAP Diet for Irritable Bowel Syndrome. PMID: 31205130
- EVALUATION OF CARBOHYDRATE AND FIBER CONSUMPTION IN PATIENTS WITH IRRITABLE BOWEL SYNDROME IN OUTPATIENT TREATMENT. PMID: 31141064
- The Impact of a 4-Week Low-FODMAP and mNICE Diet on Nutrient Intake in a Sample of US Adults with Irritable Bowel Syndrome with Diarrhea. PMID: 31103370
- Specific foods can reduce symptoms of irritable bowel syndrome and functional constipation: a review. PMID: 31080496
- Low fermentable oligosaccharides, disaccharides, monosaccharides, and polypols diet and irritable bowel syndrome in Asia. PMID: 31061894
- Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet. PMID: 31029650
- Elimination of Fermentable Carbohydrates to Reduce Gastrointestinal Symptoms in Pediatric Patients With Irritable Bowel Syndrome: A Narrative Review. PMID: 30937981
- Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence? PMID: 30935559
- Tolerability of FODMAP - reduced diet in irritable bowel syndrome - efficacy, adherence, and body weight course. PMID: 30873577
- Low FODMAPs diet for functional abdominal pain disorders in children: critical review of current knowledge. DOI: 10.1016/j.jped.2019.03.004
- Sa1942 – Real-World Implementation of the Low Fodmap Diet: Poor Compliance is Significantly Improved by Guidance from a Dietitian. DOI: 10.1016/S0016-5085(19)38008-4
- Su1580 – A Longitudinal Study Examining the Effect of Altering Fodmap Intake on the Metabolome and Pain Signaling in IBS Patients. DOI: 10.1016/S0016-5085(19)38319-2
- Mo1543 – The Effect of Low Fodmap Diet Management in Combination with Bifidobacteria on IBS Patients in Western China:A Prospective Randomized Trail. DOI: 10.1016/S0016-5085(19)38887-0
- 860 – Low Fodmap Diet in the Long Term: Efficacy, Acceptability and Individual Perception of Trigger Foods. A Pilot Study. DOI: 10.1016/S0016-5085(19)37269
- 347 – Is Sucrose the Sixth Fodmap in a Subset of Patients with Irritable Bowel Syndrome with Diarrhea and Sucrase Isomaltase Deficiency?. DOI: 10.1016/S0016-5085(19)36959-8
- Mo1548 – Efficacy, Feasibility, and Safety of the Low Fodmap Diet for Children with Irritable Bowel Syndrome: A Prospective Cohort Study and Phone Survey. DOI: 10.1016/S0016-5085(19)38892-4
- Sa1958 – Measuring Diet Intake and Gastrointestinal Symptoms in Irritable Bowel Syndrome: Validation of the Food and Symptom Times (FAST) Diary with Fodmap Analysis. DOI: 10.1016/S0016-5085(19)38024
- Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome. PMID: 30945376
- Bacillus spp. Spores-A Promising Treatment Option for Patients with Irritable Bowel Syndrome. PMID: 31438618
- Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management? PMID: 31327047
- Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. PMID: 31591348
- Effects of Low-FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial. PMID: 31586453
- Implementation of the low FODMAP diet in functional gastrointestinal symptoms: A real-world experience. PMID: 31571351
- Commentary: Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link? PMID: 31552257
- Low FODMAP diet significantly improves IBS symptoms: an Irish retrospective cohort study. PMID: 31520160
- Gluten and FODMAPS-Sense of a Restriction/When Is Restriction Necessary? PMID: 31434299
- Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones. PMID: 31394793
- Effect of Three Diets (Low-FODMAP, Gluten-free and Balanced) on Irritable Bowel Syndrome Symptoms and Health-Related Quality of Life. PMID: 31336747
- Impaired cell surface expression and digestive function of sucrase-isomaltase gene variants are associated with reduced efficacy of low FODMAPs diet in patients with IBS-D. PMID: 31331993
- Irritable bowel syndrome: how can symptoms and quality of life be improved with diet? PMID: 31313689
- Review article: biological mechanisms for symptom causation by individual FODMAP subgroups - the case for a more personalised approach to dietary restriction. PMID: 31309595
- Influence of Dietary Fiber in Low FODMAP Diet for Irritable Bowel Syndrome. PMID: 31205130
- The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders. PMID: 31850930
- Technological Methods for Reducing the Content of Fructan in Wheat Bread. PMID: 31835575
- All that a physician should know about FODMAPs. PMID: 31802437
- Effect of Structural Individual Low-FODMAP Dietary Advice vs. Brief Advice on a Commonly Recommended Diet on IBS Symptoms and Intestinal Gas Production. PMID: 31766497
- Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS). PMID: 31727345
- Literature Review: Dietary Intervention Adherence and Adherence Barriers in Functional Gastrointestinal Disorder Studies. PMID: 31714332
- The Pervasive Misunderstanding of What The FODMAP Diet Does And Does Not Do: Part 1. Today’s Practitioner
- The Pervasive Misunderstanding of What the FODMAP Diet Does and Doesn’t Do: Part 2. Today’s Practitioner
- Impact of 24-hour high and low fermentable oligo- di- mono- saccharide polyol diets on markers of exercise-induced gastrointestinal syndrome in response to exertional-heat stress. PMID: 31652404
- The long-term effect and adherence of a low fermentable oligosaccharides disaccharides monosaccharides and polyols (FODMAP) diet in patients with irritable bowel syndrome. PMID: 31637777
- Observational Study on Knowledge and Eating Habits with Respect to Low- and High-FODMAP Foods in Medical Checkup Populations in Japan. PMID: 31614902
- Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel disease. PMID: 31421429
- The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome. PMID: 31290223
- Low FODMAPs diet for functional abdominal pain disorders in children: critical review of current knowledge. DOI: 10.1016/j.jped.2019.03.004